Type 2 Diabetes Trial, Recruiting (NCT06115265)

Type 2 Diabetes Trial, Recruiting NCT06115265 Sponsor: University of New Mexico Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06115265 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older (men and women)
People with a body mass index (BMI) of 27 or higher (a measure of body weight relative to height)
People with a blood sugar marker called HbA1c of 5.7% or higher, and/or a fasting blood sugar level between 100–125 mg/dL (these ranges can indicate prediabetes)

Who may not be able to join:

People who have been diagnosed with heart or blood vessel disease, such as a previous stroke, heart attack, or poor circulation in the legs
People with LDL ("bad") cholesterol levels of 190 mg/dL or higher
People with triglyceride (a type of blood fat) levels of 500 mg/dL or higher
People with a history of type 1 diabetes
People who have previously had a serious diabetes complication called diabetic ketoacidosis
People who currently need insulin to manage their blood sugar
People with severe kidney disease
People with severe liver disease
People with a terminal cancer diagnosis
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kristen Gonzales, MD, University of New Mexico

Phone: 505-272-3840

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06115265

Sponsor: University of New Mexico

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 505-272-3840

More information: https://clinicaltrials.gov/study/NCT06115265

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older (men and women)
People with a body mass index (BMI) of 27 or higher (a measure of body weight relative to height)
People with a blood sugar marker called HbA1c of 5.7% or higher, and/or a fasting blood sugar level between 100–125 mg/dL (these ranges can indicate prediabetes)

Who may not be able to join:

People who have been diagnosed with heart or blood vessel disease, such as a previous stroke, heart attack, or poor circulation in the legs
People with LDL ("bad") cholesterol levels of 190 mg/dL or higher
People with triglyceride (a type of blood fat) levels of 500 mg/dL or higher
People with a history of type 1 diabetes
People who have previously had a serious diabetes complication called diabetic ketoacidosis
People who currently need insulin to manage their blood sugar
People with severe kidney disease
People with severe liver disease
People with a terminal cancer diagnosis
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of New Mexico

Registry

ClinicalTrials.gov

Start date

5 September 2023

Est. completion

30 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Weight in kg

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov